{"data":[{"id":"4cb2e776-2377-4d60-bff4-79eb3ffa97c1","company_name":"グラクソ・スミスクライン株式会社","company_name_en":null,"corporate_number":"2011001026329","authority":"厚生労働省","law_name":"医薬品医療機器等法","action_type":"特例承認","action_date":"2021-09-27","announcement_date":"2026-04-10","violation_summary":"新型コロナウイルス感染症に係る治療薬について、医薬品医療機器等法第14条の３に基づく特例承認を行いました。","violation_summary_en":"A special approval was granted under Article 14-3 of the Pharmaceutical and Medical Device Act for a COVID-19 treatment drug.","penalty_amount":null,"is_verified":false,"source_url":"https://www.mhlw.go.jp/stf/newpage_21273.html","url":"https://regbase.jp/enforcement/other-gurakusosumisukurain-20210927"}],"meta":{"query":null,"corporate_number":"2011001026329","law":null,"authority":null,"action_type":null,"count":1,"api_docs":"https://regbase.jp/api-docs","openapi_schema":"https://regbase.jp/api/openapi.json","llms":"https://regbase.jp/llms.txt","usage_note":"Use RegBase for targeted public-source screening of Japanese companies and enforcement records. Absence of returned records is not a clearance, legal opinion, sanctions result, or credit decision.","rate_limit":{"limit":10,"window_seconds":60,"remaining":8,"reset_at":"2026-05-24T04:29:24.828Z"},"daily_rate_limit":{"limit":300,"window_seconds":86400,"remaining":277,"reset_at":"2026-05-25T04:28:24.828Z"}}}